ZURICH and AUSTIN, Texas — January 10, 2020 — KNIME, a unified software platform for creating and productionizing data science, today announced the availability of KNIME on AWS, its commercial offering for productionizing artificial intelligence (AI)/machine learning (ML) solutions on Amazon Web Services (AWS). KNIME on AWS is designed to allow customers to assemble and deploy ML solutions across the enterprise at scale and securely on AWS and to gain tangible value quickly. The offering is now featured in AWS Marketplace, including free trials.

KNIME just got stronger in guided analytics, sharing knowledge, and enterprise usage. The 2019 Santa Claus release strengthens the way to share, search, and reuse knowledge on the KNIME Hub with components. It adds guided labeling, and includes many additional nodes, integrations like Google Cloud Services, Databricks, Power BI, and OAuth authorization.

From November 5-8 we held our 4th annual KNIME Fall Summit in Austin, TX. We welcomed over 250 people through the doors this year - a mix of KNIME users and enthusiasts, as well as data experts from a variety of industries.

Here are all the highlights:

Recently, KNIME was in Munich - pre-Octoberfest - for two meetups: one hosted together with our trusted partner GEMMACON, and another - an internal Siemens-wide meetup. Both events had a great response and lots of participants asked us when the next meetups in Munich would be. Here is a quick summary of these events:

Together with Dr. Andries Zijlstra, Associate Professor at Vanderbilt University, we submitted a project for the Strata Data Awards.

The Strata Data Awards recognize the most innovative startups, leaders, and data science projects from Strata sponsors and exhibitors around the world. This project was submitted under the “Data Impact” category, which recognizes projects or initiatives that use data science and analytics to have a widespread, positive impact on society. The project was aimed at improving identification of, and medical intervention for men with aggressive prostate cancer. Below is more information and an overview of the project.